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Abstract Human aging is characterized by changes
in the immune system which have a profound impact
on the T-cell compartment. These changes are more
frequently found in CD8+ T cells, and there are not
well-defined markers of differentiation in the CD4+
subset. Typical features of cell immunosenescence are
characteristics of pathologies in which the aberrant
expression of NKG2D in CD4+ T cells has been
described. To evaluate a possible age-related expres-
sion of NKG2D in CD4+ T cells, we compared their
percentage in peripheral blood from 100 elderly and
50 young adults. The median percentage of CD4+
NKG2D+ in elders was 5.3% (interquartile range
(IR): 8.74%) versus 1.4% (IR: 1.7%) in young
subjects (p<0.3×10
−10). CD28 expression distin-
guished two subsets of CD4+ NKG2D+ cells with
distinct functional properties and differentiation sta-
tus. CD28+ cells showed an immature phenotype
associated with high frequencies of CD45RA and
CD31. However, most of the NKG2D+ cells belonged
to the CD28
null compartment and shared their pheno-
typical properties. NKG2D+ cells represented a more
advanced stage of maturation and exhibited greater
response to CMV (5.3±3.1% versus 3.4±2%, p=
0.037), higher production of IFN-γ (40.56±13.7%
versus 24±8.8%, p=0.015), lower activation thresh-
old and reduced TREC content. Moreover, the
frequency of the CD4+ NKG2D+ subset was clearly
related to the status of the T cells. Higher frequencies
of the NKG2D+ subset were accompanied with a
gradual decrease of NAIVE and central memory cells,
but also with a higher level of more differentiated
subsets of CD4+ T cells. In conclusion, CD4+
NKG2D+ represent a subset of highly differentiated
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The human immune system progressively deteriorates
with age, which leads to a greater incidence or
reactivation of infectious diseases, as well as to the
development of autoimmune disorders and cancer
(DelaRosa et al. 2006; Prelog 2006). These defective
immune responses are also manifested in a reduced
capacity to induce immunological memory to vac-
cines and infections. In fact, the incidence of acute
transplantation rejections is significantly lower in
elderly transplant patients (Bradley 2002; Deng et al.
2004; Trzonkowski et al. 2010). Thus, aging is
characterized by a reduction in adaptive responses,
with a profound impact on the T-cell compartment.
Elders retain a relatively intact innate immunity
(Pawelec et al. 1998). It is well known that the size
of the thymus diminishes with age (Taub and Longo
2005). Thymic involution implies a decreased output
of naïve T cells, which is evident in peripheral blood
and the lymph nodes (Fagnoni et al. 2000; Sauce et al.
2009; Appay et al. 2010). In contrast, elderly donors
display a marked increase in the proportion of highly
differentiated effector and memory T cells due to a
lifetime of exposure to a variety of pathogens. In the
elderly, a significant proportion of T cells loses the
expression of costimulatory molecules and acquires
inhibitory receptors. T cells from elders exhibit
reduced responses to mitogen activation, such as
decreased proliferation and interleukin (IL)-2 produc-
tion, and also present a short telomere length, a
common property of end-stage differentiation (Effros
et al. 2005; DelaRosa et al. 2006). Accumulation of
these highly differentiated Tcells is partially explained
by their reduced susceptibility to apoptosis and their
oligoclonal expansions against CMVand other chronic
antigens (Vescovini et al. 2004; Almanzar et al. 2005;
Vasto et al. 2007; Derhovanessian et al. 2009). The
accumulation of clonal cells with pro-inflammatory
capabilities and an impaired ability to distinguish
“self” and “foreign” antigens may be contributing to
the development of autoimmune diseases (Prelog
2006). Interestingly, the most dramatic differences
between aged and young individuals have been found
in the CD8+ Tcell subset, whereas CD4+ Tcells were
more resistant to age-related phenotypic and func-
tional changes (Olsson et al. 2000; Wikby et al. 2002;
Weinberger et al. 2007; Czesnikiewicz-Guzik et al.
2008). Oligoclonal expansions within the CD4 com-
partment are rare, preferentially found in patients with
autoimmune diseases (Schmidt et al. 1996; Thewissen
et al. 2007a, b). In fact, markers of differentiation are
not as well defined in CD4+ T cells as in CD8+ T
cells. The diminished expression of CD28, which is
frequently encountered in CD8 T cells with age, is
inconsistently observed in CD4+ T cells (Goronzy et
al. 2007; Czesnikiewicz-Guzik et al. 2008).
Cellular immunosenescence is characteristic of
some pathologies in which immune activation and
inflammation become generalized. In this way, some
autoimmune diseases, such as rheumatoid arthritis
(Thewissen et al. 2005), and some infectious diseases,
such as HIV infection (Appay et al. 2007), are
characterized by an accelerated immune senescent
phenotype, which includes higher frequencies of the
CD4+ CD28
null subset. These CD4+ CD28
null T cells
exhibit increased effector functions and appear to
amplify autoimmune and inflammatory responses.
Another common property described in CD4+ T cells
from patients with these pathologies is the expression
of NKG2D (Groh et al. 2003; Alonso-Arias et al.
2009), a killer lectin-like receptor originally identified
on NK cells, TcRγδ+ cells and TcRαβ+ CD8+ T
lymphocytes, but not on normal CD4 T cells. CD4+
NKG2D+ T cells comprise a particular subset of
CD4+ T cells which have only been described in
patients with cancer, chronic autoimmune diseases,
or persistent infection (Duftner et al. 2003;A z i m ie t
al. 2006;G r o he ta l .2006; Allez et al. 2007;C a p r a r u
et al. 2008; Alonso-Arias et al. 2009). Cytomegalo-
virus (CMV) infection, a model of antigen persis-
tence with transient reactivations, has been
associated with NKG2D expression in CD4+ T cells
(Saez-Borderias et al. 2006). Mechanistically, repeat-
ed exposures to the same antigens appear to lead to
NKG2D expression in CD4+ T cells and favour the
differentiation of CD4+ T cells.
The typical features of immunosenescence and the
possible association with CMV infection shared by
patients with rheumatoid arthritis and patients with
HIVinfectionpromptedustopostulate a possiblerisein
592 AGE (2011) 33:591–605the frequency of CD4+ T cells expressing NKG2D
during aging. In this study, we describe for the first time
an increased frequency of CD4+ NKG2D+ T cells in
older people and this cellular subset is strongly
associated with a senescent phenotype in CD4+. These
NKG2D+ cells present a more advanced replicative
status with respect to CD4+ CD28
null Tc e l l s ,a n d
NKG2D+ could be a useful marker of cellular
differentiation.
Materials and methods
Study population Blood samples were obtained from
100 healthy elderly donors (75 females/25 males) in
the “El Cristo” Health Centre, the Hospital Universi-
tario Central de Asturias and the Monte Naranco
Hospital (Oviedo, Spain). The volunteers were not
rigorously selected according to their health status in
order to study a representative sample from the
population. However, those volunteers with serious
diseases such as cancer, chronic diseases (diabetes,
autoimmune diseases), or congestive heart failure, and
those receiving ongoing treatment with immunosup-
pressive drugs were excluded from participation. All
subjects were vaccinated with a trivalent influenza
vaccine (Solvay Biologicals BV, Olst, Holland). Sam-
ples from 50 young healthy controls (20 females/30
males) were obtained from the Centro de Transfusiones
del Principado de Asturias (Oviedo, Spain). Inclusion
criteria were a minimum age of 65 years for the elderly
group and a maximum age of 55 for the young group.
The mean age of the elderly individuals was 84.3±
7.7 years (range: 68–105 years) and that of the young
controls was 38.8±9.4 years (range: 18–55 years).
Informed consent was obtained from patients and
controls prior to participating in the study. The study
was approved by the Hospital Central de Asturias
Ethics Committee.
CD4+ T cell phenotyping The percentage of CD4+
NKG2D+ T cells was determined in peripheral blood
from both the young and elderly participants by
staining with anti-CD45, anti-CD3, anti-CD4 (BD
Bioscience, San Jose, CA, USA) and anti-NKG2D
(eBioscience). Whole blood samples (100 μL) were
stained with different combinations of labelled mono-
clonal antibodies for 30 min at room temperature.
Subsequently, samples were treated with FACS Lysing
Solution (BD Bioscience) to lyse red blood cells,
washed in phosphate buffered saline (PBS), and
analyzed with a FACSCalibur Cytometer and CellQuest
software. CaliBRITE Beads (BD Biosciences,San Jose,
CA, USA) were used to adjust instrument settings, set
fluorescence compensation and check instrument sensi-
tivity. BD Multicheck Control and Multicheck CD4
Low Control were used as quality controls.
Phenotypical characteristics of CD4+ NKG2D+
T subsets were also determined by flow cytometry.
CD4+ T cells (isolated as described below) were
stained with anti-NKG2D (PE), anti-CD45RA
(FITC), anti-CD45RO (PE), anti-HLA-DR (FITC),
anti-CD25 (FITC), anti-CD28 (FITC or PE), and
anti-CD31 (APC; BD Bioscience). Frequencies of
cells with intracytoplasmic stores of granzyme B
and perforin in CD4+ NKG2D+ T cells were
measured. Cells were surface stained for 20 min
at room temperature, lysed and fixed with FACS
Lysing Solution, permeabilized with BD FACS
Permeabilizing Solution 2 (Perm II; BD Biosci-
ence), and stained with anti-granzyme A-FITC or
anti-perforin-FITC for 30 min at room temperature.
Cells were washed and resuspended in 1% parafor-
maldehyde until FACS analysis.
To analyze the differentiation status of CD4+ T
cells, peripheral blood mononuclear cells (PBMC)
were isolated by centrifugation on Ficoll–Hypaque
gradients (Lymphoprep; Nycomed, Oslo, Norway).
CD4+ T cells from young (n=20) and elderly subjects
with different frequencies of CD4+ NKG2D+ (<5%,
5–20% and >20%, n=20 in each group) were isolated
(Myltenyi Biotec GmbH, Bergisch Gladbach, Ger-
many) and stained with anti-CD45RA (FITC; Immu-
nostep, Salamanca, Spain), anti-CCR7 (Alexa Fluor
647; BD Bioscience), anti-CD27 (PE; Immunostep)
and anti-CD28 (PerCP; BD Bioscience).
Quantification of telomerase activity PBMC were
separated from the blood of 20 elderly individuals
with different levels of NKG2D expression. CD4+ T
cells isolated by negative selection (Miltenyi Biotec
GmbH) were lysed and the protein concentration was
measured in the extracts. The number of telomeric
repeat sequences (TTAGGG) added to the 3′-end of
an oligonucleotide substrate was quantified using
real-time PCR (ABI 7500 Real-Time PCR Systems,
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TeloExpress Quantitative Telomerase Detection Kit
(XpressBio, Thurmont, MD, USA).
Antigen stimulation of whole blood cultures CMV-
infected cell lysate was prepared by infecting human
embryonic lung fibroblasts with the AD169 strain of
CMV. Viral titers in the supernatant were determined by
standard plaque assays. The virus was inactivated by
repeated freeze–thaw cycles. Heparinized venous blood
samples were stimulated with CMV (10
4 PFU/mL) or a
1/100 dilution of the influenza vaccine (Solvay Bio-
logicals BV) in 15-mL conical polypropylene tubes.
The blood cultures were incubated in humidified 37°C
incubator for 18 h. Activation was assessed by surface
staining with anti-CD69 (eBioscience). The cells were
also stained with anti-CD4, anti-CD28 and anti-
NKG2D. Samples were red blood cell lysed with
FACS Lysing Solution, washed in PBS, and analyzed
with CellQuest software.
Stimulation for cytokine assays PBMC (4×10
6
cells/mL) were stimulated with soluble anti-CD3
(1–10
3 ng/mL; eBioscience) for 6 h. Activation was
assessed by intracellular staining with anti-IFN-γ (BD
Biosciences), anti-IL-2 and anti-IL-17 (eBioscience).
Cultures for the detection of intracytoplasmic cytokines
weretreatedafterthefirst2hwiththesecretioninhibitor
Brefeldin A (10 μg/mL; Calbiochem, Darmstadt,
Germany). After four additional hours, cells were
treated with 2 mM EDTA for 15 min at room
temperature, washed, and stained with antibodies
against T cell surface molecules at 4°C. Intracellular
staining was performed as previously described for
granzyme B and perforin.
Virological testing DeterminationofantibodiestoCMV
in sera from elderly individuals was performed using the
VIR-ELISA test ANTI-CMV-IgG (Viro-Immun Labor-
Diagnostica GmbH, Oberursel, Germany).
T cell receptor excision circle quantification PBMC
were separated from the blood of three elderly
individuals with >20% CD4+ NKG2D+. CD4+ T
cells isolated by negative selection (Miltenyi Biotec
GmbH) were stained with anti-CD28-PE, and CD28+
cells were isolated with anti-PE magnetic microbeads.
The negative fraction was then stained with anti-
NKG2D-PE and CD4+ CD28
null T cells were
separated into NKG2D positive and negative subsets
with the aforementioned microbeads. The DNA of the
isolated subsets (purity >90%) was extracted using a
QIAamp DNA Mini Kit (Qiagen GmbH, Hilden,
Germany) according to the manufacturer’s
instructions. Quantification of signal-joint (sj) T cell
receptor excision circle (TREC) was performed by
using SYBR Green real-time quantitative PCR and an
iCycler thermocycler (Bio-Rad; Life Science Research
Group, Hercules, CA, USA). The sequences of the
utilized primers were the following: forward primer
5′-CCATGCTGACACCTCTGGTT-3′, reverse primer
5′-TCGTGAGAACG GTGAATGAAG-3′.A sa ni n t e r -
nal control measurement to normalize for input DNA,
the Cα constant region that remains present on TCR
genes despite the rearrangement processes was
amplified in every sample tested (forward primer
5′-CCTGATCCTCTTGTCCCACAG-3′, reverse prim-
er 5′-GGATTT AGAGTCTCTCAGCTGGTACA-3′).
Thermal cycling conditions were 50°C for 2 min, 95°
Cfor10min,followedby40cyclesat95°Cfor15sand
60°C for 1 min. Experimental samples were run in
duplicate and the replicate average value was taken as
the sample result.
Statistical analysis Comparisons between groups
were performed with the non-parametric Mann–
Whitney U method, Kruskal–Wallis test or with the
Wilcoxon signed-rank test when data were not
normally distributed; or with Student’s t test for
independent or paired data. The outlier value of the
CD4+ NKG2D+ T cells in normal individuals was
calculated by adding 1.5 times the interquartile range
(IR) to the 75th percentile. The χ
2 test was used to
compare dichotomous variables. Analyses were per-
formed using the SPSS 15.0 statistical software
package program (SPSS Inc. Chicago, IL, USA). P
values of 0.05 or less were considered significant.
Results
NKG2D expression in CD4+ T cells from elderly
and young individuals
To evaluate a possible age-associated expression of
NKG2D in CD4
+ T cells, we assessed the NKG2D
status on CD4+ T cells in peripheral blood cells from
594 AGE (2011) 33:591–605100 elderly volunteers and 50 young donors (Fig. 1a).
The median percentage of CD4+ T cells expressing
NKG2D was almost fourfold higher in elderly
volunteers (5.3% [IR: 8.74%]) than in young subjects
(1.4% [IR: 1.7%]) (Mann–Whitney U test, p=0.3×
10
−10; Fig. 1b). The size of the CD4+ NKG2D+ pool
was significantly different between the age groups.
Approximately 83% of the elderly individuals
displayed CD4+ NKG2D+ T cell levels higher than
2.3%, the 75th percentile in control donors (χ2t e s t ,
p=2×10
−12;O R :1 5 . 5[ C I :6 . 7 –35.5]). Despite the
decline of the absolute numbers of CD4+ T cells
with age, elderly individuals also showed higher
CD4+ NKG2D+ count than young subjects, with
30.7 (IR: 56.7) and 19.4 (IR: 18.4) cells per μL,
respectively (Mann–Whitney U test, p=0.005).
NKG2D-expressing CD4+ T cells were clearly more
abundant in the elderly volunteers when compared
with young adults.
CD4+ T cell differentiation subsets in young
and elderly people related to NKG2D expression
Our studies have demonstrated that NKG2D expres-
sion in CD4+ T cells was clearly associated with
aging; thus, NKG2D expression might represent a
biomarker for differentiation and/or immunosenes-
cence. We postulated that factors that lead to NKG2D
expression can be affecting the global memory
phenotype in CD4+ T lymphocytes. We studied the
state of differentiation of CD4 T cells in three groups
of elder individuals with different frequencies of CD4+
NKG2D+ (<5%, 5–20%, and >20%; n=20 in each
group), and in a subset of young individuals (n=20).
CD4+ T cells were isolated from peripheral blood,
stained with CD45RA, CCR7, CD28, and CD27 and
analyzed by flow cytometry. Depending on the
CD45RA and CCR7 expression, T lymphocytes were
divided into naïve (NAIVE; CD45RA+CCR7+),




−), and effector mem-
ory RA (EMRA; CD45RA+CCR7
−; Sallusto et al.
1999; Fig. 2a). A comparison between young and
elderly subjects revealed a significant decrease in the
frequency of NAIVE cells in the CD4+ T cell in all
the NKG2D groups of elderly subjects. Moreover, an
age-associated increase was found in CD4+ EM
EMRA subset. The CD4+ CM subset was only
significantly decreased in the >20% NKG2D group
and no differences in the EMRA subsets were found
(Fig. 2b and c). The increasing NKG2D expression in
the elderly was directly associated with the dimin-
ished frequencies of NAIVE and CM cells, as well as
the increased EM subsets in CD4+ T cells.
EM and EMRA are heterogeneous populations,
and the staining of two additional markers, CD27 and
CD28, has proven useful in identifying less (CD27+
and/or CD28+) or more (CD27
nullCD28
null) differen-
tiated cells (Romero et al. 2007; Koch et al. 2008). In
CD4+ T cells, EM T cells were divided into EM1
Fig. 1 CD4+ NKG2D+ T cells in peripheral blood from young
and elderly individuals. (a) Representative dot plots showing the
frequency of NKG2D expression in CD4+ T cells in elderly and
young individuals. (b) Percentages of CD4+ T cells expressing
NKG2D in a group of 100 elderly subjects compared with a
group of 50 young subjects. Whole blood was stained with
CD45-FITC/NKG2D-PE/CD3-PerCP/CD4-APC and 10
5 cells
were acquired in each experiment. Frequencies of NKG2D+
cells in gated CD45+ CD3+ CD4+ lymphocytes were analyzed.
Outlier values are represented by circles and extreme values by
stars, and were calculated by adding 1.5 and 3 times the IR to
the 75th percentile, respectively. The horizontal dotted line
illustrates the 75th percentile in young donors (2.3%). The non-
parametric Mann-Whitney U method was used to compare
frequencies between groups




nullCD28+; Fig. 3a). Functionally, EM1 and
EM4 are very similar and exhibit memory-like
properties, whereas EM3 displayed effector-like prop-
erties. Similarly, EMRA can be divided into less
differentiated pE1 (CD27+ CD28+), and the E
(CD27
nullCD28
null), the most differentiated T cell
subset. Differentiating CD4+ T cells first lose expres-
sion of CD27 and subsequently in a later phase, they
lose CD28 (Amyes et al. 2003; van Leeuwen et al.
2004). In contrast, CD8+ T cells first lose expression
of CD28 and then CD27 (Gamadia et al. 2003).
We compared the frequencies of these subsets of
CD4+ T cells in young subjects and the NKG2D-
based groups in elderly subjects. We found that the
more differentiated subsets (EM3 and E) were
increased in elderly individuals (Fig. 3b). Summa-
rized p values of these differences clearly showed that
the frequency of the subsets was associated with age
and CD4+ NKG2D+ cell frequency (Fig. 3c). Elderly
individuals in the <5% NKG2D group displayed only
minor differences in the frequency of the subsets
compared with young individuals. The frequencies of
the subsets in the NKG2D 5–20% and >20% elderly
groups became increasingly different than those of the
young adult group (Fig. 3c). The gradual changes in
the frequencies of differentiated populations in the
three NKG2D-based groups of elderly subjects in
CD4+ are presented in pie charts in Fig. 3c. Significant
increases in the more differentiated subsets, EM3 and
E, were observed, but decreases in the less differenti-
ated EM1 and pE1 subsets were detected in the elderly
groups. Significant differences were mainly detected
between the <5% and >20% NKG2D groups.
Tocorroborateifthesehighlydifferentiatedcellsalso
display features of immunosenescence, we quantified
the telomerase activity in CD4+ T cells from the three
groups of elderly subjects. We found a progressive and
significant reduction of the telomerase activity with the
increased levels of NKG2D, with a median of 2.4×10
−5
amol (IR: 2.7×10
−5amol) in <5%, 1×10
−5amol
(IR: 0.27×10
−5amol) in >5–20%, and 0.26×10
−5amol
(IR: 0.12×10
−5amol) in >20% NKG2D group (Krus-
kal–Wallis test, p=0.008; Fig. 3d).
Fig. 2 Distribution of CD4+ and CD8+ T cells into naïve,
central memory, effector memory, and effector memory RA.
CD45RA and CCR7 expression was analysed by flow
cytometry in isolated CD4+ T cells from young people (n=
20) and elderly subjects with different frequencies of NKG2D
(<5%, 5–20%, and >20%; n=20 in each group). a Schematic
model of the T cell differentiation subsets according to
CD45RA and CCR7 expression. b Representative dot plots of
the subsets defined by CD45RA and CCR7 expression for
individuals in each group. c Histograms depict cell percentage
in each subset (mean±SEM) in young (white bars) and elderly
subjects according to NKG2D expression (light grey bars <5%,
dark grey bars 5–20%, black bars >20%). Significant differ-
ences between subsets are indicated (Student’s t test or non-
parametric Mann–Whitney method). Asterisks represent signif-
icant differences with all the groups (p<0.05)
596 AGE (2011) 33:591–605Fig. 3 Distribution of EM and EMRA CD4+ T cells into
subsets defined by CD28 and CD27 expression. a Schematic
model of the EM and EMRA differentiation subsets according
to CD28 and CD27 expression. b Representative dot plots of
the subsets defined by CD27 and CD28 expression for
individuals in each group. c Individual segments of the pie
charts represent the proportions of cells with each combination
of CD28 and CD27 in the EM and EMRA CD4 T cell subsets
in young donors (n=20) and in the three NKG2D groups (<5%,
5–20%, and >20% NKG2D, n=20 in each group) of elderly
individuals. P values of differences between young and elderly
people in each NKG2D group are shown in the rectangles
below the pie charts (Student’s t test or non-parametric Mann–
Whitney method). No significant differences were represented
by white; p<0.05 by light grey; and p>0.001 by dark grey
rectangles. d Quantification of telomerase activity. CD4+ T
cells were isolated from eight individuals in <5%, seven in 5–
20%, and five in >20% NKG2D groups. The telomerase repeat
sequence product added to the oligo substrate was determined
in triplicate in the cellular extracts and the results were
corrected by the total protein content. Outlier values were
represented by circles and extreme values by stars, and
calculated by adding 1.5 and 3 times the IR to the 75th
percentile, respectively. The non-parametric Kruskal–Wallis test
was used to compare frequencies between the three groups
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is clearly related to the differentiated status and the
immunosenescence of the CD4+ T cell populations in
the elderly. Levels of CD4+ CD28
null Tc e l l sd i dn o t
distinguish those elders belonging to <5% and 5–20%
NKG2D groups in spite of the differences between
both groups (data not shown). Thus, differences
between young and elderly people are also directly
related to the expression of the NKG2D marker.
Characterization of CD4+ NKG2D+ T cells
Normally, cells found in the CD4+ NKG2D+ subset-
related pathologies had poor or no expression of
CD28. Our analysis of the presence of this costimu-
latory receptor in elderly people revealed that most of
the CD4+ NKG2D+ T cells belonged to the CD28
null
compartment, with a low proportion in the CD28
positive cells (Fig. 4a). Differences between CD4+
NKG2D+ T cell frequencies in elderly and young
people were mainly due to the CD28
null compartment
(Fig. 4a). Remarkably, the frequency of NKG2D
expression in CD4+ CD28
null T cells was very
variable, from 1.25% to 100%.
CD28 expression distinguished two subsets of
CD4+ T cells with different functional properties
and differentiation status (a in Fig. 4b). The majority
of CD4+ CD28
nullNKG2D+ T cells had a memory
phenotype previously described in CD4+ CD28
null
cells. These cells exhibited CD45RO and HLA-DR
expression, but a diminished expression of activation
marker CD25. Moreover, these CD4+ CD28
null cells
showed cytotoxic properties and had intracytoplasmic
stores of granzyme B and perforin (b and d in
Fig. 4b). In contrast, the CD4+ CD28+ T cell subset
showed CD25 expression but diminished HLA-DR
expression and an almost absence of granzyme B
a n dp e r f o r i n( ca n ddF i g .4b). This CD4+ CD28+ T
cell subset that expressed the NKG2D molecule
displayed a naïve phenotype, with significantly
higher frequencies of CD45RA (55.7±26.6%) than
the CD4+ CD28+ NKG2D
− cells (29±7.8%;
Student’s t test, p=0.04). Moreover, CD4+ CD28+
NKG2D+ displayed an increased expression of
CD31 in the CD45RA+ compartment (74.5±11.7%
versus 42.4±23%, respectively; Student’s t test,
p=0.005; Fig. 4c).
In conclusion, CD28 expression distinguished two
different subsets of CD4+ NKG2D+ T cells in elderly
people. CD28 expressing cells predominantly showed
a very immature phenotype, whereas CD28
null T cells
mainly represented a highly differentiated, memory
subset.
Activation in response to antigens
CD4+ CD28
null T lymphocytes have been described
as antigen-specific cells against chronic viral antigens,
and have been observed mainly in some autoimmune
diseases (Thewissen et al. 2007a). In order to
investigate this point in aging individuals, the
response to chronic and to recent contact antigens
was tested. We compared the induction of CD69
expression in response to CMV antigens and to
influenza vaccine in CD4+ T cells with and without
NKG2D expression from a group of 11 elderly
subjects (Fig. 5). These elders were seropositive for
CMV and had been recently vaccinated against the
influenza virus. Their response to influenza vaccine
did not show differences in the mean value of CD69
positive cells between the NKG2D+ subset at 0.6±
0.5% and the NKG2D
− subset at 0.9±1.2%. Howev-
er, there were statistically significant differences in
response to CMV (paired t test, p=0.037), with 5.3±
3.1% of NKG2D+ cells expressing CD69 but only
3.4±2% of NKG2D
− cells. Within the CD4+ CD28+
T cells, NKG2D expression did not affect the
response to both CMV and influenza vaccine (data
not shown). Since CMV increased NKG2D expres-
sion in CD4+ T cells (Saez-Borderias et al. 2006;
Alonso-Arias et al. 2009), we analyzed the evidence
of CMV infection (seropositivity) in the three groups
of elder individuals with different frequencies of
CD4+ NKG2D+ previously described (<5%, 5–20%,
and >20%). Sixteen out of the 20 individuals
belonging to the <5% NKG2D group were CMV
seropositive. Furthermore, 19 of 20 volunteers in the
5–20% and >20% groups had evidence of CMV
infection. However, one seronegative individual
belonged to the 5–20% group and another seronegative
participant was in the >20% NKG2D+ group. There-
fore, other factors in addition to CMVinfection must be
implicated in the upregulation of NKG2D expression.
These results show that CD4+ CD28
nullNKG2D+
T cells displayed phenotypic properties and antigen
responses typical of highly differentiated cells. Fur-
thermore, the expression of NKG2D seemed to be
partially explained by CMV infection.
598 AGE (2011) 33:591–605Differentiation status of elderly CD4+ CD28
null T
cells expressing NKG2D
IL-2-expressing cells are enriched in the early
differentiated subsets of CD4+ T cells, whereas IFN-
γ expression is seen at all stages of differentiation, but
are predominantly enriched in responses to persistent
antigens and late-differentiated cells (Harari et al.
2005). Following anti-CD3 stimulation for 6 h, CD4+
CD28+ T cells produced low levels of IL-2. IL-2-
producing cells were not detected in the CD4+
CD28
null subset (Fig. 6a). However, IFN-γ expression
was induced in a greater proportion of CD4+
CD28
null (mean: 28.7±9%) than in CD4+ CD28+ T
Fig. 4 Phenotypic characterization of CD4+ NKG2D+ T cells.
a Expression of CD28 was analyzed in CD4+ NKG2D+ T cells
from 20 elderly and 20 young individuals. Whole blood was
stained with CD28-FITC/NKG2D-PE/CD3-PerCP/CD4-APC
and 10
5 cells were acquired in each experiment. Histograms
depict the percentage of CD28+ NKG2D+ (black bar) and
CD28
nullNKG2D+ (white bar) cells in gated CD3+ CD4+
lymphocytes. Percentages of CD28
null and CD28+ cells within
NKG2D+ subset in elderly and young individuals are summa-
rized. b (a) Characterization of CD4+ NKG2D+ T cells related
to expression of the CD28 marker. (b) CD4+ T cells from five
aged donors were isolated and the expression of CD45RA-
FITC, CD45RO-PercP, CD25-FITC, and HLA-DR-PerCP was
analyzed in CD28
nullNKG2D+ (Bb) and in CD28+ NKGD+
cells (c). Intracellular staining of granzyme B and perforin
expression. The percentages of positive cells in the indicated
cell populations in this representative experiment were
expressed in each histogram plot. (d) Histograms summarize
the percentage of positive cells for each marker in
CD28
nullNKG2D+ and in CD28+ NKG2D+ cells (mean±
SEM). Asterisks significant differences between the groups (p
<0.05). (Student’s t test or non-parametric Mann–Whitney
method). (c) CD4+ T cells from the same donors were stained
with CD45RA-FITC/NKG2D-PE/CD28-PercP/CD31-APC.
The frequencies of CD45RA+ and CD31+ expression in the
CD45RA subset were analyzed in CD28+ NKG2D+ and in
CD28+ NKG2D
− subsets. The percentage of positive cells in
the indicated cell populations in this representative experiment
were depicted in each histogram plot. Histograms summarize
the percentage of positive cells to each marker (mean±SEM) in
CD28+ NKG2D+ (black bars) and in CD28+ NKG2D
− cells
(white bars) from five elderly donors. Student’s t test was used
to compare means between groups
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showed no significant differences in CD4+ CD28+
T cells based in NKG2D expression. However, IFN-
γ production by CD4+ CD28
null Tc e l l sw e r e
significantly different in NKG2D negative (24±
8.8%) and NKG2D positive cells (40.56±13.7%;
paired t test, p=0.015) of elderly participants
(Fig. 6b).
CD4+ CD28
null T cells presented a low activation
threshold which could be implicated in its predispo-
sition to the breakage of self-tolerance (Yung et al.
1996). In order to determine whether NKG2D status
affected response threshold of CD4+ CD28
null T cells
in elderly subjects, we measured the production of
IFN-γ by CD4+ CD28
null and CD4+ CD28+ T cells
following stimulation with 1, 10, 100 and 1000 ng/mL
of anti-CD3 (Fig. 6c). The dose–response curve
indicated that the enhanced IFN-γ production was
elicited at concentrations as low as 1 ng/mL. Anti-CD3
at 10 ng/mL stimulated maximal IFN-γ production,
while higher concentrations induced less IFN-γ.
CD28
nullNKG2D+ cells produced higher IFN-γ levels
than CD28
null NKG2D
− cells at all anti-CD3 concen-
trations tested. However, an activator effect through
NKG2D stimulation was not detected. In fact, we
performed antibody-dependent cytotoxicity assays with
CD4+ NKG2D+ T cells isolated from peripheral
blood, but ligation of NKG2D neither induced redir-
ected lysis of P815 cells, nor enhanced lysis induced
by anti-CD3 (data not shown).
Responses to low activation doses of anti-CD3
could be related to autoimmune processes frequently
described in the elderly. However, we did not detect
IL-17 production in CD4+ CD28
null T cells, regard-
less of NKG2D status (data not shown). Moreover, an
analysis of the presence of autoantibodies, detected by
indirect immunofluorescence, revealed no significant
differences between individuals with or without
NKG2D expression (data not shown).
Since NKG2D-expressing cells produce higher
levels of IFN-γ, this subset may represent a more
mature stage in the CD4+ CD28
null T cells. To test
differences in their replicative history, TREC content
was then quantified in CD4+ CD28+, CD4+
CD28
nullNKG2D
− and CD4+ CD28
null NKG2D+ T
cell subsets isolated from three elderly individuals.
TREC are episomal DNA products generated during
T cell receptor rearrangement and not duplicated
during mitosis (Hazenberg et al. 2001). Therefore,
the lowest TREC content should be observed in those
cells that have experienced the highest number of cell
divisions. CD4+ CD28+ T cells displayed a higher
TREC content than CD4+ CD28
null cells (Fig. 6d).
CD4+ CD28
nullNKG2D+ cells had the lowest TREC
content. Of note, the expression of CD57, which
characterizes highly differentiated memory CD4 and
CD8 T cells (Brenchley et al. 2003), displayed no
significant differences in frequency between both
NKG2D subsets of CD4+ CD28
null T cells (data not
shown). Taken together, these results indicated that
NKG2D expression in CD4+ CD28
null T cells was
associated with high levels of IFN-γ production and a
low activation threshold. Based on TREC, the CD4+
CD28
nullNKG2D+ subset in the elderly has under-
Fig. 5 CD69 expression in response to CMV antigens and to
the influenza vaccine. PBMCs from elderly individuals were
stimulated for 18 h and CD69 expression was evaluated by
flow cytometry. a Representative dot plots of the frequency of
CMV- and influenza vaccine-specific CD4 T cells with and
without NKG2D expression. Percentages of positive cells in
this representative experiment are expressed in dot plots. b
Histograms summarize the percentage of CD69-cells positive
for CMVand influenza vaccine in the CD4+ CD28
nullNKG2D+
(black bars) and CD4+ CD28
nullNKG2D- subsets (white bars)
obtained from 11 elderly donors. Paired t test was used to
compare paired frequencies
600 AGE (2011) 33:591–605gone more past episodes of activation and cell cycling
than CD4+ CD28
nullNKG2D
− and was in the late
stages of differentiation.
Discussion
We have demonstrated in this study that expression of
NKG2D in CD4+ T cells is significantly increased in
elderly individuals with respect to young adults. This
cell subset exhibits the typical phenotype and function
of end-differentiated cells which have undergone a
high number of cell divisions. Furthermore, immune
systems of donors with expansions of CD4+ NKG2D+
showedamaturephenotypeinCD4+Tcells,supporting
the hypothesis that NKG2D may be a useful marker for
the evaluation of the degree of differentiation of the
immune system.
Extensive research on the effect of age on immune
responses clearly indicates its profound impact on the
T-cell compartment (Pawelec et al. 1998, 2010). Thus,
the phenotypic and functional analysis of T cells in
elderly donors shows a significant decrease in naïve T
cells and a marked increase in memory and effector/
Fig. 6 Differentiated status of CD4+ subsets defined by IL-2/
IFN-γ production and TREC content. a PBMCs were stimu-
lated for 6 h with soluble anti-CD3 (1 μg/mL). The responder
cells were analyzed for intracellular IL-2-APC staining in the
indicated populations. b Cells were treated as described
previously and IFN-γ expression was analyzed by intracellular
staining. Percentages of positive cells in the indicated popula-
tions in this representative experiment are expressed on the
histogram-plots. Histograms summarize the percentage of IFN-
γ-positive cells in CD4+ CD28
null and in CD4+ CD28+
lymphocytes NKG2D− and NKG2D
+ (mean±SEM) from the
six elderly donors tested. A paired t test was used to compare
paired means. c Dose-response curves of the IFN-γ production
by CD4 subsets defined by CD28 and NKG2D expression in
response to anti-CD3. The cells were cultured for 6 h in
medium alone or with increasing concentrations of anti-CD3
(1–1,000 ng/mL). A fluorescence analysis was carried out as
previously described. One representative experiment of three is





isolated by sorting (magnetic bead separation) and the TREC
copy number was determined by real-time PCR. Experiments
were conducted in duplicate and bars represented results from
three aging donors (mean±SEM)
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2005; Taub and Longo 2005; Koch et al. 2008; Appay
et al. 2010). These changes are less frequently
described in CD4
+ than in CD8
+ T cells and there
were no well-defined markers of differentiation in the
CD4
+ subset. Towards this goal, an increased expres-
sion of NKG2D, which is almost absent in healthy
young people, can be used as a marker for the aging
of the immune system; this can be explained in part
by the accumulation of end-differentiated effector
CD4+ T cells. In pathologies such as rheumatoid
arthritis (Groh et al. 2003) and HIV infection (Alonso-
Arias et al. 2009), the expansion of the CD4+
NKG2D+ T cells has been associated with chronic
immune activation and progressive differentiation.
The extensive differentiation can limit the naïve T
cell repertoire and reduce the ability to elicit protec-
tive immunological responses (Fasth et al. 2007;
Thewissen et al. 2007a). Interestingly, the T cell
alterations observed in rheumatoid arthritis and HIV-1
infected donors are “age-inappropriate” and similar to
those observed in elderly individuals (Weyand et al.
2003; Appay et al. 2007). In both pathologies, T cell
immune senescence occurs prematurely, probably due
to the inability to generate sufficient numbers of naïve
T cells. In addition, inflammation and immune
activation become generalized and may lead to the
accumulation of highly differentiated cells over time
(Weyand et al. 2003; Appay and Sauce 2008). Among
these, CD4+ CD28
null T cells are identified as a
consequence of chronic immune stimulation by a viral
or an autoantigen, and may constitute an important
amplification mechanism.
CD28 expression distinguished two subsets of
CD4+ NKG2D+ T cells with different properties and
differentiation status. CD28-positive cells found in
young and elderly people showed a very immature
phenotype, which correlated with high frequencies of
CD45RA and CD31 coexpression. In accordance with
their phenotypic proximity to thymocytes, the fre-
quency of CD4+ CD31+ cells among CD45RA
decreases with age (Kohler and Thiel 2009). This
subset of CD4+ CD28+ T cells may represent the
“normally occurring” population of CD4+ NKG2D+
T cells, recently defined by Dai et al. (2009). This
CD4+ CD28+ subset is characterized by autoreactiv-
ity, an immunosuppressive function, regulatory prop-
erties, and a lack of conventional markers of antigen
exposure. These results may be in line with those
indicating that CD8 thymocytes upregulate NKG2D
as they complete their developmental program in the
thymic medulla before seeding the periphery (Hue et
al. 2003). They identified NKG2D as a potential
regulator of the developmental processes in T cells
which are essential for immune homeostasis. Of note,
differences between elderly and young people were
mainly due to the CD28
null compartment. The
CD28
null T cells expressed a similar pattern of
phenotypical markers and intracytoplasmic granzyme
B and perforin stores regardless of NKG2D expres-
sion. Both subsets of CD28
null showed responder cells
against CMV antigens, with higher frequencies in
NKG2D+ cells, but no response against recent contact
antigens. NKG2D expression can constitute an end-
stage maturation marker, since we have demonstrated
that these cells display a more terminally differenti-
ated phenotype. CD57 expression, which decorates
highly differentiated memory CD4 and CD8 T cells
(Appay et al. 2007, 2008), did not differ in the
NKG2D subsets of CD4+ CD28
null T cells. However,
the reduced TREC levels and the higher frequency of
responder cells to CMV among NKG2D+ cells with
respect to CD4+ CD28
nullNKG2D
− T cells may point
to an increased proliferation against specific antigens
and to a more differentiated phenotype.
This hypothesis is also supported by the enhanced
ability of NKG2D+ cells to produce IFN-γ in
response to TcR stimulation. IFN-γ expression is
present at all stages of differentiation, but is mostly
improved in late-differentiated cells that lack IL-2-
production (Yue et al. 2004; Harari et al. 2005). The
dominant IFN-γ CD4+ T cell response was associated
with models of antigen persistence and high antigen
levels. These data suggest the acquisition of NKG2D
expression is induced by repeated exposure to the
same antigens and leads to a more differentiated
subset of cells (Appay et al. 2002; Snyder et al. 2004;
Goronzy and Weyand 2005). For example, CMV
infection represents a model of antigen persistence
with transient reactivations, mainly in immunosup-
pressed individuals. CMV was previously associated
with NKG2D expression in CD4+ T cells (Saez-
Borderias et al. 2006; Alonso-Arias et al. 2009).
Although CMV infection may account for the high
number of CD4+ NKG2D+ T cells in many of the
CMV-infected elderly subjects, it does not explain the
high frequencies of CD4+ NKG2D+ in individuals
who were seronegative for CMV. These data suggest
602 AGE (2011) 33:591–605that other persistent viral infections and/or the pro-
inflammatory cytokines produced during some infec-
tious processes may drive their differentiation. An-
other possible explanation is the corroborated fact that
advanced age is accompanied by a low-grade, chronic
upregulation of inflammatory responses evidenced by
increased serum levels of proinflammatory cytokines
(IL-6, IL-15, IL-8), coagulation factors, and reactive
oxygen species (Mari et al. 1995; Forsey et al. 2003;
Zanni et al. 2003; Ferrucci et al. 2005; Wikby et al.
2006; Giunta et al. 2008).
Our most important finding related to NKG2D
expression in CD4+ T cells is its association with a
more senescent and differentiated phenotype in CD4+
T cells. Thus, the phenotypic analysis of T cells in
elderly donors showed a significant decrease in naïve
T cells and a marked increase in those with a memory
or effector/memory phenotype. Correlations between
CD4+ and CD8+ effector cells had been demonstrated
in latent CMV infection in the elderly, but to our
knowledge, this is the first time that NKG2D has been
demonstrated as a marker of differentiation in the
CD4+ T-cell compartment. We applied models that
categorize the T cell differentiation states based on
CD45RA, CCR7, CD28, and CD27 expression
(Sallusto et al. 1999; Rufer et al. 2003; Romero et
al. 2007). Although differences between these T cell
populations in young and elderly people have already
been reported, we have demonstrated that levels of
NKG2D expression define the state of differentiation
in CD4+ T cells in the elderly. Aging donors with
high frequencies of CD4+ NKG2D+ exhibited a more
differentiated CD4+ T-cell compartment. These more
differentiated CD4+ T cells can be the result of a non-
specific effect of the pro-inflammatory environment
on the differentiation state of other Tcells which leads
to higher frequencies of differentiated cells in indi-
viduals with higher levels of CD4+ NKG2D+.
Moreover, NKG2D is correlated with the senescence
status of CD4+ T cells, since telomerase activity was
reduced progressively with the increase of NKG2D
expression. When cells lack telomerase activity, telo-
meres shorten and are no longer protective and the cell
enter this non-replicative state (Campisi 1997).
In conclusion, NKG2D expression in CD4+ T cells
can be a part of the differentiation process. This
phenomenon is a consequence of the successive
rounds of activation throughout a lifetime the elderly
have gone through, and can be accelerated by the
chronic activation induced by persistent viral infec-
tions or auto-antigens.
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